Additional funding of $20 million accelerates commercialization of Trailhead’s iPSC-derived human cell and media products. BEACHWOOD, Ohio and CAMBRIDGE, Mass.,…
Read More
Collaboration with Dana-Farber Cancer Institute aims to identify biomarkers linked to treatment response for the next generation of cancer therapies…
Read More
ANDOVER, Mass., Jan. 12, 2026 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a global leader in organ transplant technologies…
Read More
Transaction follows three years of accelerated growth and successful operations under B‑FLEXION and Patient Square’s ownership. BOSTON, Jan. 12, 2026…
Read More
Preliminary fourth quarter 2025 total revenue of approximately $69.8 million, including net product sales of $65.4 million and contract revenues…
Read More